Validation of point-of-care thromboelastography (TEG 6S) in pediatric cardiac surgical patients
R
Rania Abbasi
Primary Investigator
Overview
The aim of this study is to validate the TEG 6S technology in pediatric cardiac patients by comparing its viscoelastic values with those of the standard TEG 5000.
Description
The new TEG 6S technology has been validated against the TEG 5000 in adults undergoing cardiac surgery8, however no data exists for pediatric patients.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cardiac Surgery
-
Age: - 18 Years
-
Gender: All
Inclusion Criteria
All patients, less than 18 years of age, presenting for elective cardiac surgery involving cardiopulmonary bypass.
Exclusion Criteria
Patients with known hemostatic disorders
Patients on anticoagulation or antiplatelet therapy not stopped preoperatively
Patients who are wards of the court or in foster care
Patients on anticoagulation or antiplatelet therapy not stopped preoperatively
Patients who are wards of the court or in foster care
Updated on
01 May 2024.
Study ID: 1809513681
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
